- Home
- YMAB vs MYPS Comparison
YMAB vs MYPS Comparison
Compare YMAB & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- MYPS
- Stock Information
- Founded
- YMAB 2015
- MYPS 2011
- Country
- YMAB United States
- MYPS United States
- Employees
- YMAB N/A
- MYPS N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- MYPS EDP Services
- Sector
- YMAB Health Care
- MYPS Technology
- Exchange
- YMAB Nasdaq
- MYPS Nasdaq
- Market Cap
- YMAB 192.4M
- MYPS 175.7M
- IPO Year
- YMAB 2018
- MYPS N/A
- Fundamental
- Price
- YMAB $4.32
- MYPS $1.18
- Analyst Decision
- YMAB Buy
- MYPS Buy
- Analyst Count
- YMAB 11
- MYPS 6
- Target Price
- YMAB $17.55
- MYPS $2.80
- AVG Volume (30 Days)
- YMAB 182.8K
- MYPS 317.8K
- Earning Date
- YMAB 08-11-2025
- MYPS 08-04-2025
- Dividend Yield
- YMAB N/A
- MYPS N/A
- EPS Growth
- YMAB N/A
- MYPS N/A
- EPS
- YMAB N/A
- MYPS N/A
- Revenue
- YMAB $88,658,000.00
- MYPS $274,310,000.00
- Revenue This Year
- YMAB N/A
- MYPS N/A
- Revenue Next Year
- YMAB $15.15
- MYPS $0.89
- P/E Ratio
- YMAB N/A
- MYPS N/A
- Revenue Growth
- YMAB 4.92
- MYPS N/A
- 52 Week Low
- YMAB $3.55
- MYPS $1.14
- 52 Week High
- YMAB $16.11
- MYPS $2.29
- Technical
- Relative Strength Index (RSI)
- YMAB 43.02
- MYPS 37.23
- Support Level
- YMAB $4.23
- MYPS $1.30
- Resistance Level
- YMAB $4.62
- MYPS $1.45
- Average True Range (ATR)
- YMAB 0.24
- MYPS 0.07
- MACD
- YMAB -0.03
- MYPS -0.01
- Stochastic Oscillator
- YMAB 14.04
- MYPS 14.29
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.